Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20K Buy
88
+10
+13% +$2.12K ﹤0.01% 813
2026
Q1
$14.8K Buy
78
+75
+2,500% +$14.8K ﹤0.01% 885
2025
Q4
$534 Buy
+3
New +$513 ﹤0.01% 1206
2025
Q3
– Sell
-47
Closed -$8.25K – 1322
2025
Q2
$8.25K Buy
47
+40
+571% +$7.09K ﹤0.01% 832
2025
Q1
$1.27K Sell
7
-22
-76% -$4.38K ﹤0.01% 1065
2024
Q4
$6.07K Buy
29
+14
+93% +$3.06K ﹤0.01% 856
2024
Q3
$3.22K Sell
15
-2
-12% -$403 ﹤0.01% 911
2024
Q2
$3.42K Buy
17
+2
+13% +$437 ﹤0.01% 880
2024
Q1
$3.66K Hold
15
– – ﹤0.01% 869
2023
Q4
$3.26K Buy
+15
New +$3.03K ﹤0.01% 856
2023
Q3
– Sell
-121
Closed -$26K – 570
2023
Q2
$26K Buy
121
+5
+4% +$1.05K 0.01% 567
2023
Q1
$26.8K Hold
116
– – 0.01% 539
2022
Q4
$26.5K Hold
116
– – 0.01% 516
2022
Q3
$23K Hold
116
– – 0.01% 500
2022
Q2
$21K Buy
116
+10
+9% +$1.88K 0.01% 530
2022
Q1
$20K Sell
106
-10
-9% -$2.03K ﹤0.01% 560
2021
Q4
$27K Buy
+116
New +$26.3K 0.01% 474
2021
Q3
– Sell
-101
Closed -$22K – 593
2021
Q2
$22K Buy
+101
New +$22.3K 0.01% 513

Other funds holding IEX

CVA Family Office's IEX Position: Q2 2026 in Review

CVA Family Office increased its IDEX (IEX) stake by 13% in Q2 2026, buying an estimated $2.12K and bringing the position to 88 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #813.

CVA Family Office first reported a position in IEX in Q2 2021 and has held it in 18 quarters since. The position peaked at $27K in Q4 2021. 691 funds tracked by Wall St. Rank hold IEX as of Q2 2026.

  • CVA Family Office held 88 shares of IDEX worth $20K as of Q2 2026.
  • CVA Family Office bought 10 IDEX shares in Q2 2026, an estimated $2.12K.
  • IDEX made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #813 holding.
  • CVA Family Office first reported a position in IDEX in Q2 2021 and has held it in 18 quarters since.
  • CVA Family Office's IDEX position peaked at $27K in Q4 2021.
  • 691 funds tracked by Wall St. Rank held IDEX as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.